These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29992461)
21. Adipokine levels in overweight women with early-onset gestational diabetes mellitus. Lobo TF; Torloni MR; Mattar R; Nakamura MU; Alexandre SM; Daher S J Endocrinol Invest; 2019 Feb; 42(2):149-156. PubMed ID: 29696612 [TBL] [Abstract][Full Text] [Related]
22. Circulating Betatrophin Levels and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Kong FJ; Ma LL; Li G; Chen YX; Zhou JQ PLoS One; 2017; 12(1):e0169941. PubMed ID: 28081192 [TBL] [Abstract][Full Text] [Related]
23. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus. Tsiotra PC; Halvatsiotis P; Patsouras K; Maratou E; Salamalekis G; Raptis SA; Dimitriadis G; Boutati E Peptides; 2018 Mar; 101():157-166. PubMed ID: 29337272 [TBL] [Abstract][Full Text] [Related]
24. Adipokines and β-cell dysfunction in normoglycemic women with previous gestational diabetes mellitus. Molęda P; Fronczyk A; Safranow K; Majkowska L Pol Arch Med Wewn; 2015; 125(9):641-8. PubMed ID: 26252176 [TBL] [Abstract][Full Text] [Related]
25. [The expression of visfatin in placenta in women with gestational diabetes mellitus]. Luo JX; Liu XH; Zhang L; He GL Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):204-7. PubMed ID: 21500554 [TBL] [Abstract][Full Text] [Related]
26. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Telejko B; Kuzmicki M; Zonenberg A; Szamatowicz J; Wawrusiewicz-Kurylonek N; Nikolajuk A; Kretowski A; Gorska M Diabetes Res Clin Pract; 2009 Apr; 84(1):68-75. PubMed ID: 19185944 [TBL] [Abstract][Full Text] [Related]
27. Changes in visfatin levels after oral glucose tolerance test in women with gestational diabetes mellitus. Zhaoxia L; Ying W; Danqing C Diabetes Res Clin Pract; 2012 Jun; 96(3):e76-9. PubMed ID: 22446095 [TBL] [Abstract][Full Text] [Related]
28. Serum selenium level and gestational diabetes mellitus: a systematic review and meta-analysis. Kong FJ; Ma LL; Chen SP; Li G; Zhou JQ Nutr J; 2016 Oct; 15(1):94. PubMed ID: 27793207 [TBL] [Abstract][Full Text] [Related]
29. The role of visfatin in the pathogenesis of gestational diabetes mellitus. Gok DE; Yazici M; Uckaya G; Bolu SE; Basaran Y; Ozgurtas T; Kilic S; Kutlu M J Endocrinol Invest; 2011 Jan; 34(1):3-7. PubMed ID: 20220292 [TBL] [Abstract][Full Text] [Related]
30. Serum level and polymorphisms of retinol-binding protein-4 and risk for gestational diabetes mellitus: a meta-analysis. Hu S; Liu Q; Huang X; Tan H BMC Pregnancy Childbirth; 2016 Mar; 16():52. PubMed ID: 26975349 [TBL] [Abstract][Full Text] [Related]
31. The relationship between advanced glycation end products and gestational diabetes: A systematic review and meta-analysis. Sisay M; Edessa D; Ali T; Mekuria AN; Gebrie A PLoS One; 2020; 15(10):e0240382. PubMed ID: 33085688 [TBL] [Abstract][Full Text] [Related]
32. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. Akturk M; Altinova AE; Mert I; Buyukkagnici U; Sargin A; Arslan M; Danisman N J Endocrinol Invest; 2008 Jul; 31(7):610-3. PubMed ID: 18787378 [TBL] [Abstract][Full Text] [Related]
33. Maternal serum level of resistin is associated with risk for gestational diabetes mellitus: A meta-analysis. Hu SM; Chen MS; Tan HZ World J Clin Cases; 2019 Mar; 7(5):585-599. PubMed ID: 30863758 [TBL] [Abstract][Full Text] [Related]
34. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis. Sun J; Ren J; Zuo C; Deng D; Pan F; Chen R; Zhu J; Chen C; Ye S Lipids Health Dis; 2020 Feb; 19(1):26. PubMed ID: 32087711 [TBL] [Abstract][Full Text] [Related]
35. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis. Lee YH; Bae SC Int J Rheum Dis; 2018 Mar; 21(3):664-672. PubMed ID: 28205390 [TBL] [Abstract][Full Text] [Related]
36. The role of visfatin in pathogenesis of gestational diabetes (GDM). Radzicka S; Pietryga M; Iciek R; Brązert J Ginekol Pol; 2018; 89(9):518-521. PubMed ID: 30318580 [TBL] [Abstract][Full Text] [Related]
37. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Chang YH; Chang DM; Lin KC; Shin SJ; Lee YJ Diabetes Metab Res Rev; 2011 Sep; 27(6):515-27. PubMed ID: 21484978 [TBL] [Abstract][Full Text] [Related]
38. Circulating visfatin levels and cancers risk: A systematic review and meta-analysis. Mohammadi M; Mianabadi F; Mehrad-Majd H J Cell Physiol; 2019 Apr; 234(4):5011-5022. PubMed ID: 30471099 [TBL] [Abstract][Full Text] [Related]
39. Pre-pregnancy overweight or obesity and gestational diabetes as predictors of body composition in offspring twenty years later: evidence from two birth cohort studies. Kaseva N; Vääräsmäki M; Matinolli HM; Sipola-Leppänen M; Tikanmäki M; Heinonen K; Lano A; Wolke D; Andersson S; Järvelin MR; Räikkönen K; Eriksson JG; Kajantie E Int J Obes (Lond); 2018 Apr; 42(4):872-879. PubMed ID: 29146992 [TBL] [Abstract][Full Text] [Related]
40. [Characteristics of oral glucose tolerance test in 9803 pregnant women of different pre-pregnancy body mass index and its relationship with the incidence of gestational diabetes mellitus]. Wei Y; Guo Q; Sun W; Yang H Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):830-3. PubMed ID: 26887770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]